InsidersTradesSigma
Track the Cosmo Pharmaceuticals N.V. stock price and the full insider trade history of the company, a publicly traded company based in Switzerland. Shares are listed on the CH market, under the supervision of SIX SER. Operating in the Health Care sector, Cosmo Pharmaceuticals N.V. has recorded 50 public disclosures. Market capitalisation: €1.1bn. The latest transaction was filed on 9 March 2026 (Purchase). The full history is accessible without an account.
50
Insider Decl.
n/a
Thresholds
€10m
25 ops.
Buy Volume
€7m
25 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cosmo Pharmaceuticals N.V. Strong Buy (bullish), based on 5 analysts. Average price target: CHF 122.30.
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,422 of 28,753 companies
40.2
score / 100
Value31
Quality49
FCF yld-1.7%
Earn yld-0.3%
EV/EBITDA·
ROE-1.2%
Gross mgn49%
Net mgn-3.5%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 March 2026
Declarations50 total
2,886 shares@ CHF 92.002.2% of flowISIN NL0011832936SIX:T1Q3900024
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 114.003.3% of flowISIN NL0011832936SIX:T1Q1L00069
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 110.503.2% of flowISIN NL0011832936SIX:T1Q1G00028
●
Anonymous (Executive member of the board of directors / member of senior management)
100 shares@ CHF 110.400.3% of flowISIN NL0011832936SIX:T1Q1G00010
●
Anonymous (Executive member of the board of directors / member of senior management)
2,000 shares@ CHF 109.806.3% of flowISIN NL0011832936SIX:T1Q1G00044
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 107.203.1% of flowISIN NL0011832936SIX:T1Q1F00012
●
Anonymous (Executive member of the board of directors / member of senior management)
500 shares@ CHF 106.401.5% of flowISIN NL0011832936SIX:T1Q1E00015
●
Anonymous (Executive member of the board of directors / member of senior management)
500 shares@ CHF 107.001.5% of flowISIN NL0011832936SIX:T1Q1E00064
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 107.003.1% of flowISIN NL0011832936SIX:T1Q1D00041
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 108.503.1% of flowISIN NL0011832936SIX:T1Q1700046
●
Anonymous (Executive member of the board of directors / member of senior management)
1,000 shares@ CHF 108.303.1% of flowISIN NL0011832936SIX:T1Q1600022
●
Anonymous (Executive member of the board of directors / member of senior management)
155 shares@ CHF 107.000.5% of flowISIN NL0011832936SIX:T1Q1500024
●
Anonymous (Executive member of the board of directors / member of senior management)
500 shares@ CHF 106.201.5% of flowISIN NL0011832936SIX:T1PCU00079
●
Anonymous (Executive member of the board of directors / member of senior management)
1,750 shares@ CHF 106.04595.4% of flowISIN NL0011832936SIX:T1PCU00087
●
Anonymous (Executive member of the board of directors / member of senior management)
10 shares@ CHF 108.000.0% of flowISIN NL0011832936SIX:T1PCM00068
●
Anonymous (Executive member of the board of directors / member of senior management)
1,755 shares@ CHF 80.304.1% of flowISIN NL0011832936SIX:T1PCI00082
●
Anonymous (Executive member of the board of directors / member of senior management)
1,755 shares@ CHF 80.304.1% of flowISIN NL0011832936SIX:T1PCI00066
●
Anonymous (Executive member of the board of directors / member of senior management)
468 shares@ CHF 80.301.1% of flowISIN NL0011832936SIX:T1PCI00074
542 shares@ CHF 80.300.3% of flowISIN NL0011832936SIX:T1PCH000A5
●
Anonymous (Executive member of the board of directors / member of senior management)
838 shares@ CHF 80.301.9% of flowISIN NL0011832936SIX:T1PCH00084
46,667 shares@ CHF 80.3029.6% of flowISIN NL0011832936SIX:T1PCG00037
19,000 shares@ CHF 95.8714.4% of flowISIN NL0011832936SIX:T1PCC00051
27,500 shares@ CHF 96.1820.9% of flowISIN NL0011832936SIX:T1PCB00079
●
Anonymous (Executive member of the board of directors / member of senior management)
838 shares@ CHF 97.002.3% of flowISIN NL0011832936SIX:T1PCB00087
1 shares0ISIN NL0011832936SIX:T1PCA000R6
25 of 50 declarations
About Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases. It is listed on the Swiss stock exchange XSWX.